| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | EP0485497A1 Il-2 deletion mutants |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0229110B1 Solubilization and oxidation of somatotropin from transformed microorganisms |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/13/1992 | EP0484787A2 HCV-specific peptides, process for obtaining them and their use |
| 05/13/1992 | EP0484500A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | WO1992008801A1 Bridging antibody fusion constructs |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/10/1992 | CA2095842A1 Bridging antibody fusion constructs |
| 05/06/1992 | CN1060785A Natural anti-cancer leukonuclein made from animal spleens |
| 05/05/1992 | US5110912 Purification of il-2-containing hybrid compounds |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 04/30/1992 | WO1992007268A1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like |
| 04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
| 04/29/1992 | EP0482185A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 04/29/1992 | EP0482068A1 Cytokine and hormone carriers for conjugate vaccines |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5108910 DNA sequences encoding fusion proteins comprising GM-CSF and IL-3 |
| 04/24/1992 | WO1992006994A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/24/1992 | CA2093672A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481673A2 Genes encoding the human FK-506 binding protein and a S. cerevisiae homolog, FKB1, and their expression |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/21/1992 | US5106956 Anticarcinogenic agents |
| 04/18/1992 | WO1992006999A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | CA2094259A1 Therapeutic fragments of von willebrand factor |
| 04/16/1992 | WO1992005793A1 Targeted immunostimulation with bispecific reagents |
| 04/16/1992 | CA2052928A1 Genes encoding the human fk-506 binding protein and a.s. cerevisiae homolog, fkb1 and their expression |
| 04/15/1992 | EP0480440A1 Monoclonal antibody against melanoma |
| 04/15/1992 | EP0480041A1 Fused antigen polypeptide |
| 04/15/1992 | EP0479897A1 Enzymatically binding bioactive materials to proteins |
| 04/15/1992 | EP0479834A1 Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates |
| 04/15/1992 | EP0460101A4 Immobilized cytokines |
| 04/15/1992 | EP0169234B1 Immunoassay for biologically active human interferon-gamma |
| 04/14/1992 | US5104976 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
| 04/14/1992 | US5104853 Polypeptides |
| 04/08/1992 | EP0479071A2 Polypeptide |
| 04/08/1992 | EP0478689A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1 MN? gp 120 |
| 04/08/1992 | EP0478665A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
| 04/08/1992 | CN1060112A Human c3b/c4b receptor (cr1) |
| 04/05/1992 | WO1992006377A1 Method and kit for immunoassay of propeptide of osteocalcin and proosteocalcin |
| 04/05/1992 | CA2070433A1 Method and kit for immunoassay of propeptide of osteocalcin and proosteocalcin |
| 04/02/1992 | WO1992005196A1 Aids therapy and vaccine |
| 04/02/1992 | WO1991009872A3 Hiv-1 env fragment fusion protein |
| 04/02/1992 | CA2069507A1 Aids therapy and vaccine |
| 04/01/1992 | EP0478366A2 Recombinant hybrid immunoglobulin molecules and method of use |
| 04/01/1992 | EP0477269A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
| 03/31/1992 | US5101013 Such as those obtained by enzymatic cleavage of proinsulin, ion exchanging |
| 03/31/1992 | US5100788 Method of producing and isolating igg-binding protein a fusion peptides and a vector therefor |
| 03/31/1992 | US5100784 Microbiological synthesis, escherichia host |
| 03/29/1992 | WO1992006204A1 Surface expression libraries of heteromeric receptors |
| 03/29/1992 | WO1992006176A1 Surface expression libraries of randomized peptides |
| 03/29/1992 | WO1992006116A1 Hybrid growth factors |
| 03/29/1992 | CA2092803A1 Surface expression libraries of randomized peptides |
| 03/29/1992 | CA2092802A1 Surface expression libraries of heteromeric receptors |
| 03/29/1992 | CA2069746A1 Hybrid growth factors |
| 03/28/1992 | CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use |
| 03/25/1992 | EP0476408A1 Chemical conjugation of morpholino anthracyclines to antibodies |
| 03/24/1992 | US5098829 Immunoadsorbents |
| 03/24/1992 | CA1297814C Process for production of insulin-like growth factor i and plasmid for production thereof |
| 03/24/1992 | CA1297813C Process for production of insulin-like growth factor i |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
| 03/18/1992 | EP0474789A1 Cysteine thiol-protected peptides for use in immunoassays |
| 03/18/1992 | EP0474764A1 Method to treat rheumatoid arthritis |
| 03/18/1992 | EP0474645A1 Protein complex |
| 03/18/1992 | CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies |
| 03/17/1992 | US5096593 Separation material derived from glucomannan for blood coagulation factor, preparation and use thereof |
| 03/13/1992 | WO1992004367A1 Separation of proteins and dyes |
| 03/11/1992 | EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations |
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | CN1059278A 抗体共轭物 Antibody conjugate |
| 03/05/1992 | WO1992003457A1 Entamoeba histolytica immunodominant surface antigens |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0472662A1 Antifreeze polypeptides |
| 03/04/1992 | EP0472658A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 03/03/1992 | US5093475 Hindered linking agents derived from 2-iminothiolanes and methods |
| 03/03/1992 | US5093241 C-terminal cat fusion protein and process of preparation by recombinant dna |
| 03/01/1992 | WO1992004455A1 Multidomain hematopoiesis stimulators |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/26/1992 | EP0472207A2 Hepatitis C assay utilizing recombinant antigens |
| 02/25/1992 | US5091177 Monoclonal antibodies for treatment of human non-small cell lung carcinomas |
| 02/20/1992 | WO1992002820A1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |